Moderna Inc reported 121M in Selling and Administration Expenses for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Selling And Administration Expenses Change
Acadia Pharmaceuticals ACAD:US $ 96.79M 14.87M
Acorda Therapeutics ACOR:US $ 32.37M 100K
Agios Pharmaceuticals AGIO:US $ 29.22M 4.34M
Alexion Pharmaceuticals ALXN:US $ 342.9M 101.5M
Alnylam Pharmaceuticals ALNY:US $ 153.82M 1.08M
Amgen AMGN:US $ 1.38B 130M
Arrowhead Research ARWR:US $ 17.86M 1.67M
Biogen BIIB:US $ 654.1M 16.8M
Biomarin Pharmaceutical BMRN:US $ 184.16M 9.84M
Bluebird Bio BLUE:US $ 78.58M 8.3M
Esperion Therapeutics ESPR:US $ 46.32M 14.75M
Gilead Sciences GILD:US $ 1.34B 297M
GlaxoSmithKline GSK:LN 2.5B 183M
Gw Pharmaceuticals GWPH:US 101.05M 2.71M
Intercept Pharmaceuticals ICPT:US $ 57.65M 1.62M
IONIS PHARMACEUT IONS:US $ 56.46M 4.74M
Mirati Therapeutics MRTX:US $ 29.61M 1.26M
Puma Biotechnology PBYI:US $ 39.41M 11.17M
Regeneron Pharmaceuticals REGN:US $ 414.7M 9.1M
Sangamo Biosciences SGMO:US $ 16.49M 338K
Sarepta Therapeutics SRPT:US $ 72.35M 1.22M
Seattle Genetics SGEN:US $ 165.13M 5.29M
Ultragenyx Pharmaceutical RARE:US $ 53.41M 152K
United Therapeutics UTHR:US $ 112.8M 2.9M
Vertex Pharmaceuticals VRTX:US $ 194.67M 2.59M
YTE INCY:US $ 168.86M 15.06M